🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,54 USD

Máx. histórico

178,74

2142 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,63%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,20%

Cierre anterior

18,32

Rango de hoy

18,29 – 18,81

Volumen hoy

1.397.929

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,44%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 9 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
10/09/1998 19,88 19,88 16,50 17,81 -10,38% 16,98% 11.950
09/09/1998 21,00 21,00 19,50 19,88 -1,85% 7,14% 4.250
08/09/1998 21,75 23,25 20,25 20,25 -3,57% 13,79% 4.783
04/09/1998 22,13 22,88 20,25 21,00 -5,08% 11,86% 11.433
03/09/1998 22,69 23,25 21,75 22,13 -3,28% 6,61% 2.417
02/09/1998 25,50 25,50 22,88 22,88 -8,27% 10,29% 2.633
01/09/1998 24,00 25,88 23,25 24,94 +3,91% 10,94% 6.950
31/08/1998 26,25 27,00 24,00 24,00 -8,57% 11,43% 9.383
28/08/1998 23,06 26,25 23,06 26,25 +13,82% 13,82% 6.817
27/08/1998 26,06 26,06 23,06 23,06 -9,56% 11,51% 11.150
26/08/1998 22,88 25,50 22,13 25,50 +13,33% 14,75% 17.300
25/08/1998 24,00 24,00 22,13 22,50 -1,64% 7,81% 8.550
24/08/1998 23,25 24,00 22,88 22,88 -4,69% 4,84% 3.867
21/08/1998 27,00 27,00 22,50 24,00 -7,25% 16,67% 7.300
20/08/1998 28,31 28,31 25,88 25,88 -4,17% 8,61% 7.183
19/08/1998 28,50 28,50 27,00 27,00 -5,26% 5,26% 2.250
18/08/1998 27,56 28,50 24,75 28,50 +7,04% 13,61% 4.767
17/08/1998 28,50 31,50 26,25 26,63 -4,05% 18,42% 9.650
14/08/1998 25,50 28,50 25,13 27,75 +12,12% 13,24% 8.000
13/08/1998 27,00 29,25 24,75 24,75 +0,00% 16,67% 6.600
12/08/1998 26,06 26,63 24,75 24,75 +3,13% 7,19% 6.300
11/08/1998 27,38 27,75 21,00 24,00 -13,51% 24,66% 18.250
10/08/1998 28,50 28,50 27,38 27,75 -1,33% 3,95% 3.567
07/08/1998 24,75 28,88 24,75 28,13 +11,94% 16,67% 18.300
06/08/1998 24,19 25,31 24,00 25,13 +8,06% 5,43% 11.433
05/08/1998 23,25 25,50 22,88 23,25 +1,64% 11,29% 10.867
04/08/1998 27,00 29,25 20,25 22,88 -16,44% 33,33% 18.483
03/08/1998 29,25 31,13 27,38 27,38 -7,59% 12,82% 4.983
31/07/1998 28,13 31,13 28,13 29,63 +0,00% 10,67% 8.083
30/07/1998 28,13 31,13 28,13 29,63 +6,76% 10,67% 8.867